Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Missailidis, Daniel, Annesley, Sarah J, Fisher, Paul R · Diagnostics (Basel, Switzerland) · 2019 · DOI
Quick Summary
ME/CFS is a complex condition affecting multiple body systems, and researchers are working to understand what causes it. This review shows that evidence points to problems in the immune system, nervous system, muscle function, metabolism, and gut health in ME/CFS patients. Because patients experience different symptoms and may develop the condition in different ways, finding reliable diagnostic tests remains a key challenge that researchers are actively pursuing.
Why It Matters
This comprehensive overview validates that ME/CFS has measurable biological abnormalities across multiple organ systems, counteracting the perception that the condition lacks a biomedical basis. Identifying this multi-system pathology is essential for developing diagnostic tests and targeted treatments, and understanding how different triggers might cause similar disease presentations could improve patient care and research design.
Observed Findings
- Disturbances in immunological and inflammatory pathways are documented across ME/CFS populations
- Autonomic and neurological dysfunction are consistently reported in research studies
- Muscle and mitochondrial function abnormalities are present in affected individuals
- Metabolic shifts have been identified in ME/CFS patients
- Gut physiology and microbiota disturbances are observable in the condition
Inferred Conclusions
- ME/CFS has a tangible biomedical basis involving multiple interconnected body systems rather than being psychologically-based
- Different triggering events may initiate similar downstream pathological cascades, suggesting final common pathways despite heterogeneous presentations
- Diagnostic biomarker discovery and patient stratification are essential next steps for understanding and treating ME/CFS
- The condition likely involves a far-reaching homeostatic shift affecting the entire body's regulatory systems
Remaining Questions
- Which specific biomarkers could reliably diagnose ME/CFS and distinguish it from other conditions?
- How do different triggering events (infection, stress, other stressors) converge to produce similar pathological outcomes?
- What is the causal hierarchy among the identified abnormalities—which are primary drivers and which are secondary effects?
- How should patients be stratified based on their pathophysiological profiles, and do different subgroups require different treatment approaches?
What This Study Does Not Prove
As an editorial review rather than original research, this work does not present new experimental data or prove causality for any specific mechanism. It does not establish which pathological findings are primary drivers versus secondary consequences, nor does it demonstrate that a single unifying pathological process accounts for all ME/CFS cases. The variability in presentations across patients means that findings may not apply equally to all individuals with the condition.
Topics
Tags
Metadata
- DOI
- 10.3390/diagnostics9030080
- PMID
- 31330791
- Review status
- Editor reviewed
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 7 April 2026